Stay updated with breaking news from Affimed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street brokerages forecast that Affimed (NASDAQ:AFMD – Get Rating) will announce ($0.21) earnings per share for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Affimed’s earnings. The highest EPS estimate is ($0.16) and the lowest is ($0.24). Affimed posted earnings per share of $0.01 during the same quarter last […]
Analysts predict that Affimed (NASDAQ:AFMD – Get Rating) will report sales of $9.42 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Affimed’s earnings, with the lowest sales estimate coming in at $4.42 million and the highest estimate coming in at $13.82 million. Affimed posted sales of $14.05 million […]
Affimed (NASDAQ:AFMD – Get Rating) released its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.02), Fidelity Earnings reports. Affimed had a negative net margin of 132.18% and a negative return on equity of 40.23%. During the same quarter in […]
Wall Street brokerages expect Affimed (NASDAQ:AFMD – Get Rating) to announce earnings per share of ($0.17) for the current quarter, according to Zacks. Four analysts have made estimates for Affimed’s earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.23). Affimed reported earnings per share of ($0.20) during the same quarter last year, […]
PRESS RELEASE Affimed to Host Virtual Investor Call Today to Discuss Treatment of CD30-positive Lymphoma Patients with Cord Blood-derived Natural Killer... | December 9, 2021